However, it has been shown that p53 mutation in prostatic small cell neuroendocrine carcinoma leads to a decrease in FBXW7 protein expression.39 Thus, developing new modalities to upregulate FBXW7 protein stability may be useful in combating a variety of cancers. This evidence concerns the gene TP53 and prostate small cell carcinoma.